| Fu, Junfen |
NCT03255694: A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature |
|
|
| Active, not recruiting | 2 | 360 | RoW | PEG-somatropin, Polyethylene Glycol Recombinant Human Somatropin Injection | GeneScience Pharmaceuticals Co., Ltd., Tongji Hospital, The First Hospital of Jilin University, Affiliated Hospital of Jiangnan University, The First Affiliated Hospital with Nanjing Medical University, Shanghai Children's Hospital, The Children's Hospital of Zhejiang University School of Medicine, Children's Hospital of Fudan University | Dwarfism | 06/30 | 06/30 | | |
| Mao, Jianhua |
STAMP, NCT04048161: Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome |
|
|
| Completed | 4 | 270 | RoW | Tacrolimus, Tacrolimus capsules（CYONSE®）, Mycophenolate Mofetil, Mycophenolate Mofetil Dispersible tablets（CYCOPIN®） | The Children's Hospital of Zhejiang University School of Medicine, Children's Hospital of Fudan University, Peking University First Hospital, First Affiliated Hospital of Zhongshan Medical University, Nanjing Children's Hospital, Chengdu Women and Children's Center Hospital, Tongji Hospital, Second Xiangya Hospital of Central South University, Children's Hospital of Chongqing Medical University, Children's Hospital of Soochow University, Henan Provincial People's Hospital, Shandong Provincial Hospital | Nephrotic Syndrome in Children | 05/23 | 07/23 | | |
NCT05772871: The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children |
|
|
| Recruiting | 4 | 402 | RoW | Huaiqihuang granule, Prednisone, Levamisole placebo, Levamisole, Huaiqihuang Granule placebo | Jianhua Zhou, LinkDoc Technology (Beijing) Co. Ltd. | Nephrotic Syndrome in Children | 09/25 | 10/25 | | |
STERN, NCT06125405: Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome |
|
|
| Recruiting | 3 | 20 | RoW | Telitacicept | The Children's Hospital of Zhejiang University School of Medicine | Nephrotic Syndrome in Children, Telitacicept | 10/26 | 10/27 | | |
NCT06222853: Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus |
|
|
| Recruiting | 1 | 18 | RoW | anti-CD19-CAR-T cells | The Children's Hospital of Zhejiang University School of Medicine, Chongqing Precision Biotech Co., Ltd | Systemic Lupus Erythematosus, CAR-T Cell Therapy | 12/26 | 12/26 | | |
NCT06553898: Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS |
|
|
| Recruiting | 1 | 18 | RoW | anti-BCMA/CD70 CAR-T cells | The Children's Hospital of Zhejiang University School of Medicine | Multi-Drug Resistant Nephrotic Syndrome, CAR-T Cell Therapy | 07/25 | 07/27 | | |
NCT06607991: Blinatumomab for CNI-Resistant/Intolerant SRNS in Children |
|
|
| Recruiting | 1 | 6 | RoW | Blinatumomab Treatment | The Children's Hospital of Zhejiang University School of Medicine | CNI-resistant Steriod Resistant Nephrotic Syndrome, CNI-intolerent, Steriod Resistant Nephrotic Syndrome | 09/25 | 09/27 | | |
SLE, NCT06691152: Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus |
|
|
| Recruiting | 1 | 18 | RoW | CD19 Universal CAR-T cells | The Children's Hospital of Zhejiang University School of Medicine | Systemic Lupus Erythematosus | 09/27 | 09/27 | | |
SEEK, NCT06792799: Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease |
|
|
| Not yet recruiting | 1 | 72 | RoW | anti-CD19/BCMA CAR NK cells (KN5601) | The Children's Hospital of Zhejiang University School of Medicine | Autoimmune Diseases, Systemic Lupus Erthematosus, Multi-Drug Resistant Nephrotic Syndrome | 06/28 | 06/29 | | |
NCT06508346: Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAV |
|
|
| Recruiting | N/A | 12 | RoW | anti-CD19-CAR-T cells | The Children's Hospital of Zhejiang University School of Medicine, Children's Hospital of Chongqing Medical University | ANCA Associated Vasculitis, CAR-T Cell Therapy | 07/26 | 07/27 | | |
NCT06539624: Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease |
|
|
| Recruiting | N/A | 12 | RoW | EXG110 injection | The Children's Hospital of Zhejiang University School of Medicine | Fabry Disease | 04/27 | 04/27 | | |
